Latest filing published 10 Jan 2020 for Intra-Cellular Therapies, Inc..
Filing timeline
BuySaleInsider track record
No signal scores available.
Andrew Satlin: trading record in brief
All filings by Andrew Satlin on record concern Intra-Cellular Therapies, Inc. In total, 2 filings cover trades dated from 8 January 2020 to 9 January 2020.
Every open-market trade on record is a sale: 1 sale worth €272k. Other entries cover 1 option exercise.
The latest filing, published on 10 January 2020, reports an option exercise in Intra-Cellular Therapies, Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Andrew Satlin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 22,911 sharesCommon StockSEC:0001209191-20-003150:0
- 11,573 shares@ US$26.16100.0% of flowCommon StockSEC:0001209191-20-003150:1
2 of 2 declarations
